Palmitic acid, the most common saturated free fatty acid, can lead to lipotoxicity and apoptosis when overloaded in non-fat cells. Palmitic acid accumulation can induce pancreatic β-cell dysfunction and cardiac myocyte apoptosis. Under various cellular stresses, the activation of p53 signaling can lead to cell cycle arrest, DNA repair, senescence, or apoptosis, depending on the severity/type of stress. Nonetheless, the precise role of p53 in lipotoxicity induced by palmitic acid is not clear. Here, our results show that palmitic acid induces p53 activation in a dose-and time-dependent manner. Furthermore, loss of p53 makes cells sensitive to palmitic acid-induced apoptosis. These results were demonstrated in human colon carcinoma cells (HCT116) and primary mouse embryo fibroblasts (MEF) through analysis of DNA fragmentation, flow cytometry, colony formation, and Western blots. In the HCT116 p53 −/− cell line, palmitic acid induced greater reactive oxygen species formation compared to the p53 +/+ cell line. The reactive oxygen species (ROS) scavengers N-acetyl cysteine (NAC) and reduced glutathione (GSH) partially attenuated apoptosis in the HCT116 p53 −/− cell line but had no obvious effect on the p53 +/+ cell line. Furthermore, p53 induced the expression of its downstream target genes, p21 and Sesn2, in response to ROS induced by palmitic acid. Loss of p21 also leads to more palmitic acid-induced cell apoptosis in the HCT116 cell line compared with HCT116 p53 +/+ and HCT116 p53 −/− . In a mouse model of obesity, glucose tolerance test assays showed higher glucose levels in p53 −/− mice that received a high fat diet compared to wild type mice that received the same diet. There were no obvious differences between p53 −/− and p53 +/+ mice that received a regular diet. We conclude that p53 may provide some protection against palmitic acid-induced apoptosis in cells by targeting its downstream genes in response to this stress.

The p53 tumor suppressor functions as a transcription factor and plays a pivotal role in regulation of cellular response to DNA damage by activating various genes including those involved in cell cycle arrest. p53 stability is essential for its function during stress response; however, the molecular mechanism for DNA damage-induced stabilization of p53 is not fully understood. In our present study, we have identified SMG7 (suppressor with morphological defects in genitalia 7), also known as EST1C, as a novel p53-binding protein. SMG7 is an mRNA surveillance factor implicated in degradation of p53 mRNA-containing nonsense mutations, yet it is completely unknown whether SMG7 regulates p53 function. Here, we show that SMG7 has a crucial role in p53-mediated response to genotoxic stress by regulating p53 stability. Using somatic gene knockout, we found that deletion of SMG7 abrogates DNA damage-induced p53 stabilization, although it exhibits minimal effect on the basal levels of p53. Importantly, loss of SMG7 impairs p53-mediated activation of p21 and cell cycle arrest following DNA damage. Pharmacological inhibition of Mdm2, a major E3 ubiquitin ligase for p53, restored p53 stability in gamma-irradiated SMG7-deficient cells. Furthermore, SMG7 physically interacts with Mdm2 and promotes ATM-mediated inhibitory phosphorylation of Mdm2 following ionizing radiation. Therefore, our present data demonstrate that SMG7 is critical for p53 function in DNA damage response, and reveal the SMG7-mediated phosphorylation of Mdm2 as a previously unknown mechanism for p53 regulation.

Abstract. the persistence of Bcr-Abl-positive cells in patients on imatinib therapy indicates that inhibition of the Bcr-Abl kinase activity alone might not be sufficient to eradicate the leukemia cells. Many downstream effectors of Bcr-Abl have been described, including activation of both the grb2-sos-ras-MApK and grb2-gab2-pI3K-Akt pathways. the Bcr-Abl-grb2 interaction, which is mediated by the direct interaction of the grb2 sH2 domain with the phospho-Bcr-Abl y177, is required for activation of these signaling pathways. therefore, disrupting their interaction represents a potential therapeutic strategy for inhibiting the oncogenic downstream signals of Bcr-Abl. Adenovirus Ad-sH2-HA expressing the grb2 sH2 domain was constructed and applied in this study. As expected, Ad-sH2-HA efficiently infected cMl cells and functioned by binding to the phospho-Bcr-Abl y177 site, competitively disrupting the grb2 sH2-phospho-Bcr-Abl y177 complex. they induced potent anti-proliferation and apoptosis-inducing effects in cMl cell lines. Moreover, the ras, MApK and Akt activities were significantly reduced in the Ad-sH2-HA treated cells. these were not observed with the point-mutated control adenovirus Ad-sm-HA with abolished phospho-Bcr-Abl y177 binding sites. these data indicate that, in addition to the direct targeting of Bcr-Abl, selective inhibition of its downstream signaling pathways may be a therapeutic option for cMl, and the Ad-sH2-HAmediated killing strategy could be explored as a promising anti-leukemia agent in cMl.

No abstract